Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Laleh Golkar Melstrom

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6279-7981; OpenAlex author ID A5025468423. Sources: OpenAlex.

Their work

Papers
19 (first author 3, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
69
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 3 papers · 2018: none · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 4 papers · 2026: 3 papers

Papers 19

  1. The Best Patients for Effective Radiation of Pancreatic Cancer. First author DOI 10.1001/jamasurg.2026.3702↗
  2. Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
  3. Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41591-026-04775-y↗
  4. Pancreatic Cancer Immunotherapy: A Team-Based Approach. Co-author DOI 10.1007/978-3-031-97242-3_11↗
  5. Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade. Last author DOI 10.1016/j.hpb.2025.06.009↗
  6. Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.02.038↗
  7. Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice. Co-author DOI 10.1172/jci179014↗
  8. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations. Last author DOI 10.3390/curroncol31090361↗
  9. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  10. Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review. Co-author DOI 10.3390/cancers14235725↗
  11. Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King. Last author DOI 10.1002/jso.26415↗
  12. Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer. Last author DOI 10.7150/ijbs.60473↗
  13. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis. Co-author DOI 10.1002/cam4.2491↗
  14. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment. First author DOI 10.1016/j.ajpath.2018.09.009↗
  15. The pancreatic cancer microenvironment: A true double agent. Co-author DOI 10.1002/jso.24643↗
  16. Accelerating progress in the fight against pancreatic cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research. Co-author DOI 10.1002/jso.24672↗
  17. New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer. First author PMID 28620900↗
  18. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Co-author DOI 10.1136/gutjnl-2011-300821↗
  19. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2010.10.041↗

Closest collaborators

The 25 strongest of 69 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vincent M. Chung · 7 shared papers, 2019–2026 · strength 1.31
  2. Yuman Fong MD · 5 shared papers, 2017–2026 · strength 1.28
  3. Mustafa Raoof · 6 shared papers, 2019–2026 · strength 1.12
  4. Thuy Xuan Phan · 3 shared papers, 2021–2025 · strength 0.68
  5. Percy P. Lee · 2 shared papers, 2022–2025 · strength 0.43
  6. Paul Wong · 2 shared papers, 2021–2025 · strength 0.42
  7. John S. Bolton · 2 shared papers, 2026 · strength 0.39
  8. Caiming Xu · 2 shared papers, 2026 · strength 0.39
  9. Mitsuro Kanda · 2 shared papers, 2026 · strength 0.39
  10. Derek Cridebring · 2 shared papers, 2026 · strength 0.39
  11. Scott A. Celinski · 2 shared papers, 2026 · strength 0.39
  12. Eunsung Jun · 2 shared papers, 2026 · strength 0.39
  13. Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.39
  14. Carlos Roberto Becerra · 2 shared papers, 2026 · strength 0.39
  15. Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
  16. Haiyong Han · 2 shared papers, 2026 · strength 0.39
  17. David L. Bartlett · 2 shared papers, 2026 · strength 0.39
  18. Alessandro Mannucci · 2 shared papers, 2026 · strength 0.39
  19. Joon Oh Park · 2 shared papers, 2026 · strength 0.39
  20. Erkut Hasan Borazanci · 2 shared papers, 2026 · strength 0.39
  21. Ajay Goel · 2 shared papers, 2026 · strength 0.39
  22. Song Cheol Kim · 2 shared papers, 2026 · strength 0.39
  23. Dong Shang · 2 shared papers, 2026 · strength 0.39
  24. Daniel D. Von Hoff · 2 shared papers, 2026 · strength 0.39
  25. Arya Amini · 2 shared papers, 2021–2022 · strength 0.34

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.